Clinical Trial Update: A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP） [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating recombinant human thrombopoietin plus cyclosporin A versus cyclosporin A for steroid-resistant/relapsed immune thrombocytopenia has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Cyclosporin A (cyclosporine)
• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia | Phase 3 | Status: WITHDRAWN